Sign in
Taking people in United StatesNo phase

Group thinking skills training addressing race-based stress in mild cognitive impairment

Tests thinking skills training for minority elders with mild cognitive impairment.

Key facts

Who runs it
Rosalind Franklin University of Medicine and Science
Where
Chicago, United StatesSee the site
Trial code
Registry title
Race-Based Stress and Cognitive Training for MCI
Status
Recruiting
People taking part
9 people, planned
Started
1 Mar 2025
Expected to end
15 Mar 2028
Type of study
Interventional, 2 groups
Treatments tested
  • Race Based Stress and Empowerment Focused Compensatory Cognitive Training for Mild Cognitive Impairment (RBSEF-CCT-MCI)
  • Motivationally Enhanced Compensatory Cognitive Training for Mild Cognitive Impairment (ME-CCT)
Record updated
24 July 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 65 or older who identify as Black/African American and have mild memory or thinking problems. They take part in group cognitive training for 8 weeks at Rosalind Franklin University.

Age
65 Years and older
Sex
All sexes
Disease stage
At least mild cognitive impairment, or self-reported thinking difficulties. People with dementia cannot join.

Main reasons for not taking part

  • A diagnosis of dementia (major neurocognitive disorder), or screening test (RBANS) scores pointing to dementia
  • Intellectual disability
  • Mild head injury (concussion) within the last six months
  • History of moderate to severe traumatic brain injury
  • Not able to travel to Rosalind Franklin University for in-person sessions

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • The study will be conducted in-person, so they must be able to travel to Rosalind Franklin University
  • The study will initially be limited to participants who self-identify as Black/African American, or who self-identify with other racial/ethnic groups in addition to self-identifying as Black/African-American; however, may be expanded to include participants that identify as Hispanic/Latine

Who cannot take part

  • Participants will also be excluded if they have a diagnosis of dementia (i.e., major neurocognitive disorder), intellectual disability, mild head injury (i.e., concussion) within the last six months, and/or a history of moderate to severe traumatic brain injury
  • Diagnosis of dementia may be from self-report or other medical records, or for participants to fail screening cognitive assessments (i.e., the RBANS) that would suggest they may be at the level of dementia (i.e., major neurocognitive disorder) as ultimately determined by study PI with objective scores less then 2 standard deviations below the mean on the RBANS
  • Participants are ineligible to participate in this study if they are not at least 65 years of age and are not experiencing at least mild cognitive impairment or self-reported cognitive difficulties

This trial is currently available in United States.

  • Rosalind Franklin University of Medicine and ScienceChicago, United StatesContact: Rachael Ellison, PhDTaking people

About the trial

What the trial wants to find out

This a two phase project that aims to pilot a new adaptation (Phase 1) of Motivationally Enhanced Compensatory Cognitive Training for Mild Cognitive Impairment (ME-CCT; an originally VA-based cognitive rehabilitation manualized intervention for older adults with MCI, with a focus on the impact of stress on cognitive functioning; that integrates components from the Race Based Stress and Empowerment (RBSE) group for an increased focus on race-based stress and discrimination for racial minority older adults (i.e., RBSEF-CCT-MCI). In a pilot open trial, 75-150 participants will receive group-based intervention for 8 weeks, with 8-10 participants per group.

Read full original descriptionShow less

Following the pilot study, the investigators will complete a randomized controlled trial (RCT) (Phase 2) to compare the efficacy of the RBSEF-CCT-MCI with the ME-CCT. In the RCT, 75-150 participants will be randomized into either 1) The active control group, who will complete the original, ME-CCT training program, or 2) The experimental group, who will complete the newly developed RBSE-CCT-MCI. Both research groups will complete the interventions for 8 weeks, with 8-10 participants per group.

Hypothesis: Participation in this newly developed/updated intervention (i.e., RBSEF-CCT-MCI) will result in improvements in both (a) subjective and (b) objective cognitive functioning, and (c) self-reported mental health symptoms.

The 2 groups in the trial

  • Experimental: RBSEF-CCT-MCITreatment being tested

    Participants will complete the newly developed RBSE-CCT-MCI training program.

    Treatment: Race Based Stress and Empowerment Focused Compensatory Cognitive Training for Mild Cognitive Impairment (RBSEF-CCT-MCI)

  • Control Group: ME-CCTOther group

    Participants will complete the original, ME-CCT training program.

    Treatment: Motivationally Enhanced Compensatory Cognitive Training for Mild Cognitive Impairment (ME-CCT)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Race Based Stress and Empowerment Focused Compensatory Cognitive Training for Mild Cognitive Impairment
Plain-language title
Group thinking skills training addressing race-based stress in mild cognitive impairmentGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Record updated
24 July 2025